Michael W Bonney sold $5.1M of Alnylam Pharmaceuticals (ALNY)

Executed Aug 18 2025, disclosed Aug 19 2025, 1 day later.

Value, as filed

$5.1M

11,250 sh × $450.00

Executed

Aug 18 2025

the trade date, as filed

Disclosed

Aug 19 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Michael W Bonney Director profile →

Michael W Bonney (Director) filed 2 Form 4 reports in the past 24 months (0 purchases, 2 sales), most often in Alnylam Pharmaceuticals, Inc. (ALNY). The largest single filing was $5.1M of ALNY (11,250 sh × $450.00, as filed), executed Aug 18 2025.

The name

ALNY

Alnylam Pharmaceuticals, Inc. ALNY · Healthcare · 56 filings in 24 months ticker →

Healthcare · Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Michael W Bonney in ALNY

ALNYSALE Alnylam Pharmaceuticals, Inc. $3.0M
10,704 sh across 12 lots
Exec May 15 2025
Filed May 19 2025 · 5:30 PM ET